Trial Profile
Clinical Trials Insight: 700013850
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2008
Price :
$35
*
At a glance
- Drugs Sufentanil (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Labtec
- 17 Jul 2006 New trial record.